|
Delayed
OTC Markets
19:06:37 28/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | - |
| 12-29 | Motion for Asset Sale Approved for Seelos Therapeutics, Inc. | CI |
| 21/10/25 | GLD Partners, LP acquired Select assets from Seelos Therapeutics, Inc. (OTCPK : SEEL.Q). | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | - | - | - | - | - | 1 | |
| +0.65% | -3.36% | -11.99% | +15.75% | +57.11% | +36.98% | +60.50% | +6.07% | - | 64.14B | |
| +1.48% | +3.19% | -4.71% | +4.23% | +12.78% | +12.81% | +84.82% | +212.24% | +5,674.29% | 55.53B | |
| +1.06% | +1.88% | +9.59% | +11.34% | +19.00% | +13.15% | +105.46% | -14.73% | +242.61% | 53.03B | |
| -1.23% | -0.27% | +3.19% | +12.12% | +23.14% | +27.43% | +56.68% | +6.18% | +286.91% | 45.99B | |
| +0.29% | -2.08% | +2.48% | +14.40% | +23.21% | +18.89% | +100.59% | +4.64% | +1,026.14% | 42.45B | |
| +1.28% | +0.82% | -7.46% | +4.59% | +137.56% | +226.13% | +931.17% | +542.95% | - | 40.45B | |
| +0.64% | -3.95% | +6.45% | +6.99% | +10.10% | +11.15% | +45.57% | +7.13% | +158.47% | 32.25B | |
| -0.98% | +45.59% | +66.77% | +106.96% | +90.63% | +107.85% | +94.07% | +33.98% | +245.62% | 34.47B | |
| -2.72% | -0.44% | -15.78% | +14.42% | +43.32% | +23.18% | -10.77% | -61.94% | - | 24.23B | |
| +1.20% | -0.96% | -9.90% | -4.45% | -6.71% | -14.07% | -4.76% | -68.14% | - | 22.1B | |
| +14.80% | +14.44% | -5.92% | +5.50% | -37.49% | -34.84% | +357.10% | +260.83% | +738.14% | 21.18B | |
| -1.23% | +4.93% | +10.30% | +17.31% | +22.17% | +17.38% | +183.79% | +202.89% | +2,264.56% | 19.38B | |
| +0.01% | +10.54% | +26.87% | +59.91% | +88.22% | +108.42% | +128.22% | -16.32% | +394.82% | 17.85B | |
| -0.05% | +3.60% | +13.20% | +25.67% | +38.24% | +42.34% | +84.59% | -15.38% | +108.41% | 16.69B | |
| +0.60% | +2.51% | +14.15% | +21.00% | +52.75% | +69.79% | +230.78% | +211.25% | +532.20% | 16.42B | |
| +1.48% | +4.09% | +10.90% | +0.35% | - | - | - | - | - | 16.39B | |
| +0.84% | +2.13% | +3.90% | +7.62% | +183.22% | +166.23% | +345.61% | +1,427.61% | +795.27% | 15.33B | |
| +0.03% | +14.82% | +24.98% | +19.49% | +16.84% | +28.29% | -10.59% | -25.76% | +165.20% | 16.04B | |
| +0.97% | -2.23% | -7.44% | -12.02% | +11.63% | +3.84% | +435.21% | - | - | 13.21B | |
| Average | +0.98% | +3.70% | +6.82% | +17.43% | +43.65% | +48.05% | +178.78% | +159.62% | +971.74% | 28.36B | |
| Weighted average by Cap. | +0.88% | +3.56% | +5.08% | +17.52% | +42.29% | +46.77% | +168.07% | +122.92% | +1,268.00% |
- Stock Market
- Stocks
- SEELQ Stock
- Sector Seelos Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
